Skip to main content
OpenTrials

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

9,074 public trials 1,776 recruiting studies
Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Completed

Virtual Reality Intervention for the Reduction of Behavioral and Psychological Symptoms of Dementia

NCT04769024

Conditions
Alzheimer Disease, Alzheimer's Disease, Brain Diseases, +12 more
Locations
  • EHPAD du Centre Hospitalier du Pays de Craponne Sur Arzon Craponne-sur-Arzon, France
  • EHPAD du Centre Hospitalier Emile Roux Le Puy-en-Velay, France
  • EHPAD Saint-Joseph Le Puy-en-Velay, France
  • EHPAD Maison Saint-François d'Assise Lyon Lyon, France
View Trial Details
Completed

A Study of Clenbuterol (CST-103) Co-administered With Nadolol (CST-107) in Subjects With Neurodegenerative Disorders

NCT04739423

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +12 more
Locations
  • The University of Sydney Sydney, New South Wales, Australia
  • Wesley Medical Research Ltd Brisbane, Queensland, Australia
  • Royal Melbourne Hospital Melbourne, Victoria, Australia
  • NZBRI Christchurch, New Zealand
View Trial Details
Completed

An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy

NCT03921528

Conditions
Atrophy, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +19 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Stanford University Palo Alto, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • The Johns Hopkins University Baltimore, Maryland, United States
View all 16 locations
View Trial Details
Completed

ATRi Transition Rollover Study

NCT03309150

Conditions
Advanced Stage Solid Tumors, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +9 more
Locations
  • Royal Marsden NHS Foundation Trust Sutton, United Kingdom
View Trial Details
Completed

A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4)

NCT05108922

Conditions
Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +9 more
Locations
  • Neurology Center of North Orange County Fullerton, California, United States
  • Irvine Clinical Research Irvine, California, United States
  • California Neuroscience Research Medical Group, Inc. Sherman Oaks, California, United States
  • Institute for Neurodegenerative Disorders New Haven, Connecticut, United States
View all 31 locations
View Trial Details

Related conditions